Antisense Therapeutics Limited (ANP.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
At close: 03:39PM AEDT
| Previous close | 0.0910 |
| Open | 0.0940 |
| Bid | 0.0870 x 50000000 |
| Ask | 0.0900 x 34112000 |
| Day's range | 0.0880 - 0.0940 |
| 52-week range | 0.0730 - 0.1750 |
| Volume | |
| Avg. volume | 291,127 |
| Market cap | 58.876M |
| Beta (5Y monthly) | 0.80 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0150 |
| Earnings date | 21 Feb 2023 - 27 Feb 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 0.31 |
- Simply Wall St.
We're Not Very Worried About Antisense Therapeutics' (ASX:ANP) Cash Burn Rate
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
- GlobeNewswire
Long COVID-19 study identifies novel blood markers as potential diagnostic and therapeutic targets
World first study utilizing Somalogic SomaScan® assay# to assess up to 7,000 plasma proteins in Long COVID-19 patients has elucidated novel blood markers as potential diagnostic and therapeutic targetsProvisional patent applications have been filed in the United States (US) to seek protection for these new inventionsA potential therapeutic marker known to be modulated by ATL1102 in DMD patients has been identified as suggestive of its therapeutic potential as a treatment for Long COVID-19Collabo
- Simply Wall St.
We're Hopeful That Antisense Therapeutics (ASX:ANP) Will Use Its Cash Wisely
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
© 2023 Yahoo. All rights reserved.
